For relief of the inflammatory and pruritic manifestations of corticosteroid-responsive
dermatoses, particularly dry, scaling localized lesions.
DOSAGE AND ADMINISTRATION
Occlusive dressings may be used for the management of psoriasis or recalcitrant
If an infection develops, the use of Cordran Tape (flurandrenolide tape) and other occlusive dressings
should be discontinued and appropriate antimicrobial therapy instituted.
Replacement of the tape every 12 hours produces the lowest incidence of adverse
reactions, but it may be left in place for 24 hours if it is well tolerated
and adheres satisfactorily. When necessary, the tape may be used at night only
and removed during the day.
If ends of the tape loosen prematurely, they may be trimmed off and replaced
with fresh tape.
The directions given below are included on a separate package insert for the
patient to follow unless otherwise instructed by the physician.
APPLICATION OF CORDRAN TAPE (flurandrenolide tape)
IMPORTANT: Skin should be clean and dry before tape is applied.
Tape should always be cut, never torn.
DIRECTIONS FOR USE:
- Prepare skin as directed by your physician or as follows: Gently clean the
area to be covered to remove scales, crusts, dried exudates, and any previously
used ointments or creams. A germicidal soap or cleanser should be used to
prevent the development of odor under the tape. Shave or clip the hair in
the treatment area to allow good contact with the skin and comfortable removal.
If shower or tub bath is to be taken, it should be completed before the tape
is applied. The skin should be dry before application of the tape.
- Remove tape from package and cut a piece slightly larger than area to be
covered. Round off corners.
- Pull white paper from transparent tape. Be careful that tape does not stick
- Apply tape, keeping skin smooth; press tape into place.
REPLACEMENT OF TAPE:
Unless instructed otherwise by your physician, replace tape after 12 hours.
Cleanse skin and allow it to dry for 1 hour before applying new tape.
IF IRRITATION OR INFECTION DEVELOPS, REMOVE TAPE AND CONSULT PHYSICIAN.
4 mcg/sq cm-small roll, 24 in x 3 in (60 cm x 7.5 cm)
4 mcg/sq cm-large roll, 80 in x 3 in (200 cm x 7.5 cm) NDC 55515-014-80
Directions for the patient are included in each package.
Store at 25°C (77°F); excursions permitted to15-30°C (59-86°F).
Bard JW: Flurandrenolide tape in the treatment of lichen simplex chronicus.
J Ky Med Assoc 1969;67:668.
Baxter DL, Stoughton RB: Mitotic index of psoriatic lesions treated with anthralin,
glucocorticosteroid and occlusion only. J Invest Dermatol 1970;54:410.
Compilation of clinical reports on Cordran Tape (flurandrenolide tape) received by Eli Lilly and Company.
Halprin KM, Fukui K, Ohkawara A: Flurandrenolone (Cordran) tape and carbohydrate
metabolizing enzymes. Arch Dermatol 1969;100:336.
Labow TA, Eisert J, Sanders SL: Flurandrenolide tape in treatment of psoriasis.
NY State J Med 1969;69:3138.
Ronchese F: Flurandrenolone tape therapy. RI Med J 1969;52:389.
Sellers FM: Investigative study of flurandrenolone tape in a series of ambulatory
outpatients. J Indiana State Med Assoc 1970;63:34.
Weiner MA: Flurandrenolone tape, a new preparation for occlusive therapy, J
Invest Dermatol 1966;47:63.
Mfd. by 3M Company, St. Paul, MN 55144. Mfd. For: Oclassen DERMATOLOGICS,
A Division of Watson Pharma, Inc. Corona, CA 92880. FDA revision date: 7/19/2000